by Patrick Bedford | Feb 26, 2018
Regenerative medicine researchers are making enormous strides to discover more about diseases and disease treatments. From heart regeneration to cancer immunotherapies to gene therapies, they are doing some of the most exciting research today, and some of them are...
by Stacey Johnson | Feb 23, 2018
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember...
by Samantha Payne | Feb 16, 2018
In many regenerative medicine strategies, we know that one strategy is usually not enough. Stimulating regeneration in any tissue is a complex, multifaceted problem involving the coordination of many biological signals. Yet what if we could deliver a therapeutic, like...
by David Kent | Feb 6, 2018
In my last post, I drew our readers’ attention to an excellent article by Giulio Cossu and colleagues on stem cells and regenerative medicine where the authors set out a number of recommendations for the regenerative medicine field. One of those recommendations was...
by Stacey Johnson | Feb 2, 2018
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event...
by David Kent | Jan 22, 2018
Over the Christmas break, I finally got around to reading an article that has been in my “to read” pile for far too long. For anybody new to the regenerative medicine and cellular therapy fields, it is an absolutely fantastic resource to catch up on some of the...
by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
by Sowmya Viswanathan | Jan 8, 2018
In this month’s blog on addressing specific bioprocess and bioanalytical challenges to develop Cell and Gene Therapies (CGTs), we hear from Dr. Nick Timmins on quantifying performance of CGTs using cell yield, and some of the methods to measure it, as a metric...
by Stacey Johnson | Dec 22, 2017
This time of year is special for many reasons, and traditions are a big part of that. It’s risky to mess with traditions; many people look forward to, and value, the familiarity and ritual of repeating something they have done for years, or even decades. You might...
by Stacey Johnson | Dec 15, 2017
If I say the names Kirsty Duncan, Mona Nemer, Julie Payette and Molly Shoichet, what comes to mind? There are many ways to answer that question, of course, but the answer I’m looking for is that they are all female scientists or engineers who hold significant...
Comments